House of Lords Business
Show full summary

Lord Rennard to ask Her Majesty's Government, following the publication of Prevalence and economic burden of medication errors in the NHS in England, funded by the Department of Health Policy Research Programme, what estimate they have made of (1) the number of cases, and (2) the costs, of adverse drug events associated with (a) aspirin, (b) diuretics, (c) warfarin, and (d) non-steroidal anti-inflammatory drugs, medication errors in primary and secondary care.  HL6206

Question HL6206: tabled on 8 March 2018 and due for answer by 22 March 2018

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Rennard to ask Her Majesty's Government, following the publication of Prevalence and economic burden of medication errors in the NHS in England, funded by the Department of Health Policy Research Programme, what estimate they have made of (1) the number of cases, and (2) the costs, of adverse drug events associated with (a) aspirin, (b) diuretics, (c) warfarin, and (d) non-steroidal anti-inflammatory drugs, medication errors in primary and secondary care.  HL6206
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Date Answered

Thursday 22 March 2018

Member's Registered Interests

There are no interests to show.

Main Member

Lord Rennard
Liberal Democrat
Life peer